Rubber Products · Founded 1986 · www.apcotex.com · BSE 523694 · NSE APCOTEX IND · ISIN INE116A01032
No Notes Added Yet
Business
Apcotex Industries Ltd. is a leading Indian manufacturer of synthetic latex and synthetic rubber. The company primarily produces various grades of Vinyl Pyridine Latex (VP Latex), Styrene Butadiene Latex (SB Latex), Styrene Acrylic Latex, Nitrile Butadiene Rubber (NBR), and High Styrene Rubber (HSR). These products are critical raw materials used in a wide range of industries including paper & paperboard coating, carpet back-coating, construction chemicals, textiles, automotive components, footwear, gloves, tires, and other industrial rubber goods. Apcotex operates on a B2B model, supplying specialty chemicals and polymers to other manufacturers.
Revenue Mix
Apcotex primarily derives its revenue from two main product categories:
Synthetic Latex: This segment includes SB Latex, VP Latex, and Styrene Acrylic Latex, which are widely used in applications like paper & paperboard coating, carpet back-coating, construction, and textiles. This is generally the larger contributor to revenue.
Synthetic Rubber: This segment includes Nitrile Butadiene Rubber (NBR) and High Styrene Rubber (HSR), used in automotive components, industrial rubber products, footwear, and specialized applications like asbestos-free gaskets and friction materials.
(Specific percentage contribution varies by financial period and is not fixed).
Industry
Apcotex operates in the specialty chemicals and synthetic rubber/latex industry in India, which is characterized by a mix of domestic players and imports. The industry is capital-intensive and requires significant R&D for product development and customization. Apcotex is one of the larger and more established players in India for its specific product lines, particularly in VP Latex and certain grades of SB Latex. It differentiates itself through a broad product portfolio, customized solutions, and technical expertise. Competition comes from other domestic manufacturers as well as imports from global players.
MOAT
Apcotex possesses several competitive advantages:
Product Diversification & Customization: A wide range of specialized products catering to diverse end-use industries allows for cross-selling and reduces dependency on a single sector. Their ability to customize products for specific customer needs creates sticky relationships.
Technical Expertise & R&D: Strong in-house R&D capabilities enable the development of new products, process improvements, and technical support to customers, leading to high switching costs for complex applications.
Scale & Market Leadership: Being a significant player in specific latex and rubber grades in India provides economies of scale in manufacturing and procurement.
Long-standing Customer Relationships: Established relationships with key industrial clients built over decades.
Growth Drivers
Growth in End-User Industries: India's robust growth in sectors like automotive, construction, packaging (paper & paperboard), and infrastructure will drive demand for Apcotex's products.
"Make in India" Initiative: Government focus on domestic manufacturing could lead to import substitution and increased demand for locally produced raw materials.
Capacity Expansion: Any planned capacity expansions for existing or new product lines would directly contribute to volume growth.
New Product Development: Introduction of innovative, higher-margin specialty products or entry into new application areas.
Export Opportunities: Tapping into international markets, particularly in developing economies, could provide additional growth avenues.
Risks
Raw Material Price Volatility: Key raw materials (e.g., Butadiene, Styrene Monomer, Acrylonitrile, Vinyl Acetate Monomer) are petrochemical derivatives, making the company susceptible to crude oil price fluctuations and supply chain disruptions.
Intense Competition: Competition from domestic players and cheaper imports can put pressure on pricing and margins.
Economic Slowdown: A downturn in India's industrial or manufacturing sectors (e.g., automotive, construction) would directly impact demand for Apcotex's products.
Regulatory & Environmental Risks: Compliance with evolving environmental regulations can lead to increased operational costs or necessitate significant capital expenditure.
Currency Fluctuations: Exposure to foreign exchange risk due to import of raw materials and potential exports.
Management & Ownership
Apcotex Industries is promoted by the Thakkar family, with Mr. Balakrishna D. Thakkar serving as the Chairman and Managing Director. The promoters hold a significant stake in the company, aligning their interests with minority shareholders. The management team has extensive experience in the specialty chemicals and polymer industry. Their operational history suggests a focus on R&D, capacity utilization, and managing raw material price volatility.
Outlook
Apcotex Industries is well-positioned to benefit from India's industrial growth, given its strong presence in critical raw materials for diverse sectors. The company's diversified product portfolio, technical expertise, and focus on specialty products offer resilience against sector-specific downturns and allow for margin expansion. However, profitability remains susceptible to the inherent volatility of raw material prices, which are linked to global crude oil trends, and intense competition. While capacity expansions and new product development could drive significant growth, effectively managing input costs and navigating competitive pressures will be crucial for sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 257 | 311 | 337 | 351 | 355 | 349 | 376 | 337 | 331 | 398 |
| Other Income | 2 | 2 | 2 | 3 | 5 | 1 | 3 | 5 | 3 | 7 |
| Total Income | 259 | 313 | 339 | 354 | 360 | 350 | 378 | 341 | 335 | 404 |
| Total Expenditure | 232 | 279 | 305 | 324 | 328 | 311 | 337 | 296 | 288 | 343 |
| Operating Profit | 27 | 33 | 34 | 30 | 32 | 39 | 41 | 45 | 47 | 61 |
| Interest | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 3 | 2 | 2 |
| Depreciation | 8 | 8 | 10 | 11 | 11 | 11 | 11 | 12 | 12 | 14 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | -5 | 0 |
| Profit Before Tax | 15 | 21 | 20 | 15 | 16 | 24 | 26 | 36 | 28 | 45 |
| Provision for Tax | 4 | 6 | 5 | 4 | 5 | 8 | 7 | 11 | 5 | 10 |
| Profit After Tax | 11 | 15 | 15 | 11 | 12 | 17 | 19 | 25 | 22 | 35 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 11 | 15 | 15 | 11 | 12 | 17 | 19 | 25 | 22 | 35 |
| Adjusted Earnings Per Share | 2.1 | 3 | 2.9 | 2.1 | 2.2 | 3.2 | 3.7 | 4.9 | 4.3 | 6.7 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 268 | 388 | 526 | 626 | 496 | 541 | 957 | 1080 | 1125 | 1392 | 1441 | 1442 |
| Other Income | 8 | 31 | 8 | 8 | 6 | 5 | 8 | 7 | 8 | 10 | 17 | 18 |
| Total Income | 276 | 419 | 534 | 634 | 502 | 546 | 965 | 1087 | 1132 | 1403 | 1459 | 1458 |
| Total Expenditure | 231 | 359 | 462 | 557 | 461 | 471 | 817 | 921 | 1011 | 1268 | 1264 | 1264 |
| Operating Profit | 45 | 60 | 72 | 77 | 40 | 75 | 148 | 166 | 122 | 135 | 195 | 194 |
| Interest | 3 | 4 | 3 | 3 | 2 | 4 | 3 | 5 | 16 | 17 | 11 | 11 |
| Depreciation | 9 | 12 | 12 | 12 | 13 | 15 | 14 | 15 | 32 | 42 | 50 | 49 |
| Exceptional Income / Expenses | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Profit Before Tax | 33 | 43 | 56 | 62 | 25 | 57 | 130 | 146 | 75 | 76 | 135 | 135 |
| Provision for Tax | 9 | 8 | 17 | 15 | 8 | 13 | 32 | 38 | 21 | 22 | 33 | 33 |
| Profit After Tax | 25 | 35 | 39 | 47 | 17 | 44 | 99 | 108 | 54 | 54 | 101 | 101 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 25 | 35 | 39 | 47 | 17 | 44 | 99 | 108 | 54 | 54 | 101 | 101 |
| Adjusted Earnings Per Share | 4.8 | 6.7 | 7.5 | 9 | 3.2 | 8.5 | 19.1 | 20.8 | 10.4 | 10.4 | 19.6 | 19.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 4% | 10% | 22% | 18% |
| Operating Profit CAGR | 44% | 6% | 21% | 16% |
| PAT CAGR | 87% | -2% | 18% | 15% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 37% | -0% | 11% | 14% |
| ROE Average | 17% | 13% | 18% | 17% |
| ROCE Average | 20% | 16% | 22% | 21% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 187 | 223 | 246 | 278 | 251 | 305 | 396 | 476 | 522 | 553 | 621 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 1 | 23 | 6 | 26 | 125 | 94 | 62 | 32 |
| Other Non-Current Liabilities | -2 | 7 | 7 | 8 | 12 | 18 | 17 | 23 | 35 | 32 | 36 |
| Total Current Liabilities | 96 | 67 | 91 | 91 | 111 | 122 | 165 | 180 | 272 | 351 | 298 |
| Total Liabilities | 281 | 297 | 344 | 377 | 397 | 452 | 605 | 803 | 922 | 999 | 986 |
| Fixed Assets | 90 | 88 | 79 | 76 | 125 | 145 | 157 | 384 | 384 | 385 | 362 |
| Other Non-Current Assets | 39 | 70 | 75 | 86 | 67 | 94 | 145 | 97 | 112 | 106 | 129 |
| Total Current Assets | 152 | 140 | 190 | 215 | 205 | 213 | 303 | 323 | 426 | 508 | 494 |
| Total Assets | 281 | 297 | 344 | 377 | 397 | 452 | 605 | 803 | 922 | 999 | 986 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 4 | 9 | 6 | 31 | 32 | 33 | 25 | 17 | 30 | 38 | 49 |
| Cash Flow from Operating Activities | -64 | 22 | 53 | 39 | 36 | 75 | 48 | 121 | 40 | 85 | 203 |
| Cash Flow from Investing Activities | 86 | -8 | -10 | -8 | -42 | -37 | -67 | -179 | -20 | -29 | -57 |
| Cash Flow from Financing Activities | -17 | -17 | -18 | -30 | 7 | -46 | 12 | 71 | -13 | -44 | -141 |
| Net Cash Inflow / Outflow | 5 | -3 | 25 | 1 | 1 | -8 | -8 | 13 | 8 | 11 | 5 |
| Closing Cash & Cash Equivalent | 9 | 6 | 31 | 32 | 33 | 25 | 17 | 30 | 38 | 49 | 54 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.76 | 6.75 | 7.45 | 8.99 | 3.21 | 8.52 | 19.06 | 20.82 | 10.39 | 10.43 | 19.56 |
| CEPS(Rs) | 6.48 | 9.08 | 9.79 | 11.26 | 5.79 | 11.32 | 21.78 | 23.76 | 16.48 | 18.45 | 29.12 |
| DPS(Rs) | 1.8 | 1.8 | 2.4 | 3 | 3 | 3.5 | 5 | 5.5 | 5.5 | 6.5 | 8 |
| Book NAV/Share(Rs) | 36.1 | 42.99 | 47.52 | 53.57 | 48.47 | 58.91 | 76.41 | 91.81 | 100.64 | 106.7 | 119.78 |
| Core EBITDA Margin(%) | 12.51 | 6.63 | 11.84 | 11.04 | 6.95 | 12.92 | 14.61 | 14.65 | 10.07 | 8.91 | 12.23 |
| EBIT Margin(%) | 12.18 | 10.92 | 10.85 | 10.41 | 5.44 | 11.2 | 13.96 | 13.91 | 7.96 | 6.68 | 10.06 |
| Pre Tax Margin(%) | 11.18 | 10.04 | 10.34 | 9.85 | 4.96 | 10.49 | 13.62 | 13.44 | 6.58 | 5.44 | 9.29 |
| PAT Margin (%) | 8.25 | 8.09 | 7.17 | 7.44 | 3.35 | 8.17 | 10.33 | 9.97 | 4.76 | 3.86 | 6.99 |
| Cash Profit Margin (%) | 11.24 | 10.89 | 9.42 | 9.33 | 6.05 | 10.85 | 11.8 | 11.38 | 7.55 | 6.83 | 10.4 |
| ROA(%) | 10.68 | 12.1 | 12.05 | 12.93 | 4.3 | 10.41 | 18.7 | 15.33 | 6.25 | 5.63 | 10.22 |
| ROE(%) | 17.2 | 17.06 | 16.47 | 17.78 | 6.29 | 15.87 | 28.17 | 24.75 | 10.8 | 10.06 | 17.27 |
| ROCE(%) | 21.21 | 20.62 | 23 | 23.89 | 9.28 | 19.53 | 34.88 | 28.04 | 13.53 | 12.97 | 20.12 |
| Receivable days | 80.88 | 68.36 | 59.69 | 61.05 | 73.63 | 65.46 | 50.85 | 50.39 | 54.83 | 59.54 | 62.69 |
| Inventory Days | 35.73 | 37.07 | 31.75 | 28.41 | 39.65 | 38.99 | 27.26 | 32.41 | 37.1 | 34.24 | 33.45 |
| Payable days | 59.56 | 39.58 | 36.85 | 42.82 | 53.68 | 71.18 | 54.96 | 54.14 | 57.71 | 58.77 | 70.85 |
| PER(x) | 18.08 | 19 | 26.49 | 23.27 | 24.68 | 21.04 | 18.7 | 23.4 | 42.4 | 31.91 | 16.05 |
| Price/Book(x) | 2.38 | 2.98 | 4.15 | 3.9 | 1.63 | 3.04 | 4.66 | 5.31 | 4.38 | 3.12 | 2.62 |
| Dividend Yield(%) | 2.09 | 1.4 | 1.22 | 1.43 | 3.79 | 1.95 | 1.4 | 1.13 | 1.25 | 1.95 | 2.55 |
| EV/Net Sales(x) | 1.72 | 1.75 | 1.96 | 1.72 | 0.89 | 1.72 | 1.97 | 2.46 | 2.17 | 1.34 | 1.16 |
| EV/Core EBITDA(x) | 10.18 | 11.37 | 14.33 | 14.01 | 10.97 | 12.37 | 12.79 | 16.01 | 20.08 | 13.85 | 8.6 |
| Net Sales Growth(%) | -24.43 | 44.6 | 35.6 | 18.91 | -20.73 | 9 | 76.99 | 12.86 | 4.13 | 23.81 | 3.53 |
| EBIT Growth(%) | -6.19 | 29.58 | 23.96 | 11.36 | -58.54 | 124.08 | 120.68 | 12.69 | -40.14 | 3.81 | 56.1 |
| PAT Growth(%) | -0.04 | 41.81 | 10.44 | 20.62 | -64.32 | 165.58 | 123.75 | 9.24 | -50.08 | 0.35 | 87.57 |
| EPS Growth(%) | -0.04 | 41.81 | 10.44 | 20.62 | -64.32 | 165.58 | 123.75 | 9.24 | -50.08 | 0.34 | 87.57 |
| Debt/Equity(x) | 0.14 | 0.1 | 0.07 | 0.01 | 0.2 | 0.05 | 0.13 | 0.32 | 0.35 | 0.33 | 0.15 |
| Current Ratio(x) | 1.58 | 2.07 | 2.1 | 2.37 | 1.85 | 1.75 | 1.84 | 1.79 | 1.57 | 1.45 | 1.66 |
| Quick Ratio(x) | 1.13 | 1.41 | 1.56 | 1.84 | 1.32 | 1.29 | 1.31 | 1.21 | 1.11 | 1.06 | 1.23 |
| Interest Cover(x) | 12.13 | 12.49 | 21.31 | 18.63 | 11.18 | 15.89 | 41.05 | 29.77 | 5.77 | 5.4 | 13.03 |
| Total Debt/Mcap(x) | 0.06 | 0.03 | 0.02 | 0 | 0.12 | 0.02 | 0.03 | 0.06 | 0.08 | 0.11 | 0.06 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 |
| FII | 0.51 | 0.48 | 0.49 | 0.48 | 0.47 | 0.52 | 0.49 | 0.59 | 0.62 | 0.63 |
| DII | 0.43 | 0.56 | 0.62 | 0.59 | 0.59 | 0.6 | 0.91 | 2.09 | 2.13 | 2.13 |
| Public | 40.83 | 40.73 | 40.66 | 40.7 | 40.72 | 40.66 | 40.37 | 39.08 | 39.02 | 39.01 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 |
| FII | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| DII | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.11 | 0.11 | 0.11 |
| Public | 2.12 | 2.11 | 2.11 | 2.11 | 2.11 | 2.11 | 2.09 | 2.03 | 2.02 | 2.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +4% | +10% | +22% | +18% |
| Operating Profit CAGR | +44% | +6% | +21% | +16% |
| PAT CAGR | +87% | -2% | +18% | +15% |
| Share Price CAGR | +37% | 0% | +11% | +14% |
| ROE Average | +17% | +13% | +18% | +17% |
| ROCE Average | +20% | +16% | +22% | +21% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 |
| FII | 0.51 | 0.48 | 0.49 | 0.48 | 0.47 | 0.52 | 0.49 | 0.59 | 0.62 | 0.63 |
| DII | 0.43 | 0.56 | 0.62 | 0.59 | 0.59 | 0.6 | 0.91 | 2.09 | 2.13 | 2.13 |
| Public | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 | 41.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 | 3.02 |
| FII | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| DII | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.11 | 0.11 | 0.11 |
| Public | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.